Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2015
At a glance
- Drugs Squalamine (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 09 Feb 2015 According to an Ohr Pharmaceutical media release, final data for this trial is expected in the first half of 2015.
- 09 Feb 2015 Status changed from recruiting to completed,as reported by ClinicalTrials.gov.
- 10 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.